1. Altered Leukocyte Sphingolipid Pathway in Breast Cancer
   Larissa Maia et al, 2017, International Journal of Molecular Sciences CrossRef
2. Preclinical study of the antitumor effect of sphingosine-1-phosphate receptor 1 antibody (S1PR1-antibody) against human breast cancer cells
   Shujun Xiao et al, 2019, Investigational New Drugs CrossRef
3. The Importance of Sphingosine Kinase in Breast Cancer: A Potential for Breast Cancer Management
   Dutt S Patel et al, 2021, Cureus CrossRef
4. Chronic inflammation evoked by pathogenic stimulus during carcinogenesis
   Björn L.D.M. Brücher et al, 2019, 4open CrossRef
5. Multiple strategies for the treatment of invasive breast carcinoma: A comprehensive prospective
   Shivangi Agarwal et al, 2022, Drug Discovery Today CrossRef
6. Sphingosine Kinase 1 Regulates the Survival of Breast Cancer Stem Cells and Non-stem Breast Cancer Cells by Suppression of STAT1
   Ling-Wei Hii et al, 2020, Cells CrossRef
7. The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target
   Samar Sami Alkafaas et al, 2024, Cancer Cell International CrossRef
8. Increased Sphingosine Kinase 1 Expression Is Associated with Poor Prognosis in Human Solid Tumors: A Meta-Analysis
   Chuanmeng Zhang et al, 2022, Disease Markers CrossRef
9. Phospho-Sphingosine Kinase 1 Expression in Lymphatic Spread of Esophageal Squamous Cell Carcinoma
   Mariko Nemoto et al, 2019, Journal of Surgical Research CrossRef
10. Protein Kinase Targets in Breast Cancer
    Marilina García-Aranda et al, 2017, International Journal of Molecular Sciences CrossRef
11. Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer
    L. C. Hanker et al, 2021, Journal of Cancer Research and Clinical Oncology CrossRef
12. Generation of sphingosine-1-phosphate is enhanced in biliary tract cancer patients and is associated with lymphatic metastasis
    Yuki Hirose et al, 2018, Scientific Reports CrossRef
13. Pathoepigenetics: The Role of Epigenetic Biomarkers in Disease Pathogenesis
    Ramón Cacabelos, 2019, Pharmacoepigenetics CrossRef
14. Identifying novel sphingosine kinase 1 inhibitors as therapeutics against breast cancer
    Faez Iqbal Khan et al, 2020, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
15. Upregulation of sphingosine kinase 1 is associated with recurrence and poor prognosis in papillary thyroid carcinoma
    Jie Li et al, 2019, Oncology Letters CrossRef
16. Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer
    Sonam Roy et al, 2020, ACS Omega CrossRef